Home › Pheochromocytoma › Iowa › Cedar Rapids
Pheochromocytoma clinical trials in Cedar Rapids, IA
3 studies for Pheochromocytoma are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
- University of Iowa ( Site 0104), Iowa City · 25 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- University of Iowa, Iowa City · 25 mi away
About Pheochromocytoma
Pheochromocytoma is a rare tumor. Pheochromocytomas often cause the adrenal gland to make too many hormones. This can lead to high blood pressure.
More about Pheochromocytoma on MedlinePlus
Pheochromocytoma trials in other cities
- Washington, DC9 studies
- Nashville, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
- Baltimore, MD3 studies
- Los Angeles, CA3 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer17 studies
- Cancer (all types)16 studies
- Acute Myeloid Leukemia16 studies
- Multiple Myeloma15 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Prostate Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Melanoma10 studies
- Stroke10 studies
- Endometrial Cancer10 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.